Knowledge of and attitude toward human papillomavirus infection and vaccines among female nurses at a tertiary hospital in Nigeria by Makwe, Christian Chigozie & Anorlu, Rose Ihuoma
© 2011 Makwe and Anorlu, publisher and licensee Dove Medical Press Ltd.  This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Women’s Health 2011:3 313–317
International Journal of Women’s Health Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
313
OrIgInAL reseArcH
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/IJWH.S22792
Knowledge of and attitude toward human 
papillomavirus infection and vaccines among 
female nurses at a tertiary hospital in nigeria
christian chigozie Makwe
rose Ihuoma Anorlu
Department of Obstetrics and 
gynaecology, college of Medicine, 
University of Lagos, Lagos, nigeria
correspondence: christian chigozie Makwe 
Department of Obstetrics and 
gynaecology, college of Medicine,  
University of Lagos/Lagos University  
Teaching Hospital, PMB 12003, Idi-Araba,  
Lagos, nigeria 
Tel +234 803 335 8021 
email makwe285@yahoo.com; 
ccmakwe@unilag.edu.ng
Background: Persistent infection with high-risk types of human papillomavirus (HPV) is 
a prerequisite for the development of cervical cancer. Highly immunogenic HPV vaccines have 
been developed and licensed for the primary prevention of cervical cancer in some developed 
and developing countries. This calls for assessment of the knowledge of the HPV infection and 
the acceptability of the HPV vaccines among health care providers.
Objective: The aim of this study was to assess awareness and knowledge of HPV infection and 
vaccines and to assess attitude toward these vaccines among female nurses at Lagos University 
Teaching Hospital, Lagos, Nigeria.
Study design: The study was a cross-sectional, descriptive study using a pretested, structured, 
anonymous, self-administered, 19-item questionnaire.
Results: A total of 178 female nurses were interviewed during a 4-week period. The mean 
age of respondents was 37.1 ± 3.1 years. Almost all (99.4%) of the respondents had heard of 
cervical cancer, while about 85% of them had heard of HPV infection. Only a quarter (25.3%) 
of respondents had heard of the HPV vaccines, and of those only 26.7% knew the vaccines 
were for the prevention of cervical cancer. Most (70.2%) of the nurses expressed a desire to 
be vaccinated and 120 (67.4%) supported the vaccination of preadolescent girls. Those who 
expressed a willingness to be vaccinated were more likely to recommend HPV vaccination for 
preadolescent girls.
Conclusion: Overall, there was a poor knowledge of the HPV vaccines among female nurses at 
Lagos University Teaching Hospital. Despite this poor knowledge, most of the nurses expressed 
a strong desire to be vaccinated and their intention to recommend it for preadolescent girls. The 
main reason given overall for not recommending the vaccines was lack of information. There 
is an urgent need to bridge this information gap.
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Introduction
Human papillomavirus (HPV) is one of the most common sexually transmitted 
infections.1,2 Over 50% of sexually active women are exposed to at least one HPV type 
during their lifetime.2 HPV infection occurs in women of all age groups and the highest 
rates of HPV infection are seen in women 20–24 years old.3 Most genital HPV infections 
are asymptomatic, transient, and resolve spontaneously without causing any disease. 
Genital HPV types have been classified as either high risk (mainly types 16 and 18) 
or low risk (mainly types 6 and 11), reflecting their potential risk of causing malignant 
lesions. Persistent infection of the cervix uteri with specific high-risk types of HPV 
is a prerequisite for the development of cervical intraepithelial neoplasia and cervical 
cancer.4 HPV types 16 and 18 cause approximately 70% of cervical cancers.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Cancer of the cervix uteri is the second most common 
cancer in women and is the most common gynecologic 
  malignancy worldwide.5 There were about 530,232 new cases 
in 2008 alone, and 85.5% of these occurred in developing 
countries.5 Cervical cancer is a major public health problem 
and it is the leading cause of cancer-related deaths among 
women in developing countries.6 It is hoped that the available 
HPV vaccines will markedly reduce the burden of cervical can-
cer and other HPV-related diseases in developing countries.
There are two types of HPV vaccine that have received 
regulatory approval for use in cervical cancer prevention 
programs worldwide. These vaccines are prepared with 
recombinant technology, using purified L1 structural proteins 
that self-assemble to form HPV type-specific empty shells or 
virus-like particles (VLPs). There is a bivalent HPV-16/18 
VLP vaccine and a quadrivalent HPV-6/11/16/18 VLP 
  vaccine. The vaccines are best administered prior to exposure 
to the virus, ideally during preadolescence (ie, 9–13 years 
of age).7
Several studies, mostly from developed countries, have 
shown that the knowledge of HPV infection and vaccines and 
the acceptability of these vaccines among health care provid-
ers and the general public vary from low to high.8–17 Nurses in 
developing countries play an important role in immunization 
programs, particularly those for vaccine-preventable child-
hood diseases. Nurses administer these vaccines and provide 
health education to the public. Therefore, the awareness and 
knowledge of HPV infection and the attitude toward HPV 
vaccines among nurses will greatly influence the success of 
an immunization program against cervical cancer. The aim 
of this study was to assess awareness and knowledge of HPV 
infection and vaccines and to assess attitude toward these 
vaccines among female nurses at Lagos University Teaching 
Hospital, Lagos, Nigeria.
Materials and methods
This prospective, cross-sectional, descriptive study was 
performed in the outpatient clinics, wards, theater, and the 
Accident and Emergency Unit of Lagos University Teaching 
Hospital, from January 21, 2008, to February 15, 2008. There 
were 415 female nurses in employment at the time of the 
study. The hospital is a 750-bed tertiary health care facility, 
which serves as a referral center for Lagos and its environs 
(Lagos has a population of about 15 million people).
The sample size was calculated using a formula for finite 
population. Assuming that 50% of the female nurses had 
sufficient knowledge of genital HPV infection, a minimum 
sample of 215 female nurses was calculated with 95% 
  confidence and 5% reliability. The entire population of 
female nurses in the hospital was selected for the study. The 
questionnaire was delivered by hand during working hours 
and was collected after completion. The objectives of the 
study were explained to the nurses and their verbal consent 
was obtained before they were given a pretested, structured, 
anonymous, self-administered, 19-item questionnaire with 
both closed and open-ended questions. The questions sought 
information on sociodemographic characteristics, on aware-
ness and knowledge of cervical cancer, HPV infections, and 
HPV vaccines, and on acceptance of these vaccines.
Data entry and analysis was performed using Epi Info™ 
(v 3.2.2; Centers for Disease Control and Prevention, Atlanta, 
GA) statistical software. Descriptive statistics were generated 
and data presented as a mean (standard deviation) or median 
(range) for continuous variables and as a percentage for 
categorical variables. Comparisons of categorical responses 
were evaluated using χ2-test or Fisher’s exact test. A P-value 
of ,0.05 was considered to be statistically significant.   Ethical 
approval was obtained from the Health Research Ethics 
  Committee of Lagos University Teaching Hospital.
Results
sociodemographic characteristics
Two hundred and thirty questionnaires were distributed 
and 178 female nurses completed and returned their 
  questionnaires. The response rate was 75.7% and the data 
were complete for all 178 respondents. Sociodemographic 
characteristics of the respondents are outlined in Table 1. The 
mean age was 37.1 ± 3.1 years. One hundred and   sixteen 
(65.2%) of the respondents were married, 56 (31.5%) were 
single, three (1.7%) were separated/divorced, and three 
(1.7%) were widowed. One hundred and sixty-five (92.7%) 
were Christians and 13 (7.3%) were Muslims. Most (38.8%) 
respondents were staff nurse midwives.
Awareness and knowledge of HPV 
infection and vaccines
One hundred and seventy-seven of the nurses (99.4%) had 
heard of cervical cancer and 151 (84.8%) had heard of HPV 
infection (see Table 2). The majority (70.1%) of them were 
aware of the association between cervical cancer and HPV 
infection. Most (72.9%) of the nurses who had heard of 
cervical cancer knew it could be prevented by Pap smear, 
while only 13% of them knew it could be prevented through 
vaccination.
About 90% of the nurses who had heard of HPV infection 
knew that it could be transmitted through sexual intercourse, International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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while only eleven (7.3%) knew it could be transmitted by 
skin-to-skin contact. Less than half of the respondents who 
had heard of genital HPV infection knew that it could be pre-
vented by vaccination (31.8%) and condom use (33.1%).
Most (74.7%) of the respondents had never heard of the 
HPV vaccines. Among the 45 nurses who had heard of the 
vaccines, only twelve (26.7%) knew they were for the preven-
tion of cervical cancer, while 30 (66.7%) respondents thought 
they were for the prevention of HPV infection.
HPV vaccine acceptability
As Table 2 shows, 125 (70.2%) of the nurses stated they 
would want to be vaccinated, while 53 (29.8%) were unwill-
ing to be vaccinated; the main reason given for unwillingness 
was insufficient knowledge about the HPV vaccines.
The majority (67.4%) of respondents supported vaccina-
tion of preadolescent girls, while 58 (32.6%) did not. The 
reasons given for not recommending HPV vaccination for 
preadolescent girls included (1) they are too young; (2) they 
are not yet sexually active; (3) they are not at risk for HPV 
infection; (4) vaccination will encourage premarital sex; 
and (5) the respondent had insufficient knowledge about the 
vaccines and its complications. Almost all the participants 
(99.4%) expressed a desire to have more information on 
HPV vaccines.
The awareness of HPV infection, cervical cancer, and the 
vaccines had no significant association with the willingness 
to be vaccinated or the intention to recommend the vaccine 
for preadolescent girls. The nurses who were willing to be 
vaccinated were more likely to recommend the vaccines for 
preadolescent girls (P , 0.001) (Table 3).
Discussion
The knowledge of HPV infection and vaccines among nurses 
in this study was relatively low. Despite the fact that many 
were aware of cervical cancer and HPV infection, a   relatively 
Table 1 sociodemographic characteristics (n = 178)
Age distribution (years) Respondents (n) Respondents (%)
20–29 56 31.4
30–39 50 28.1
40–49 50 28.1
$50 22 12.4
Marital status
single 56 31.5
Married 116 65.2
Divorced/separated 3 1.7
Widowed 3 1.7
Religion
christian 165 92.7
Muslim 13 7.3
Tribe
Yoruba 96 53.9
Ibo 42 23.6
Other 40 22.5
Position/Designation
cnO 25 14.0
Assistant cnO 15 8.4
Principal nO 33 18.5
senior nO 14 7.9
nO 22 12.4
staff nurse midwife 69 38.8
Abbreviations: CNO, chief nursing officer; NO, nursing officer; n, number.
Table 2 Awareness and knowledge of cervical cancer, human 
papillomavirus (HPV) infection, and HPV vaccines, and acceptability 
of these vaccines (n = 178)
Question Yes (n) Yes (%)
ever heard of cervical cancer? 177 99.4
ever heard of HPV infection? 151 84.8
ever heard of HPV vaccine? 45 25.3
Would you want to receive a vaccine 
that can prevent cervical cancer?
125 70.2
Would you support vaccination  
of preadolescent girls?
120 67.4
Knowledge of cervical cancera Correct response
(n) (%)
cervical cancer is the commonest  
gynecological cancer in nigeria
171 96.6
cervical cancer is caused by 
HPV infection
124 70.1
cervical cancer is preventable 164 92.7
How can cervical cancer be  
prevented?
  Pap smear 129 72.9
  Vaccination 23 13.0
Knowledge of HPV infectionb
HPV infection is associated with  
genital warts
117 77.5
How is HPV infection transmitted?
  sexual contact 135 89.4
  skin-to-skin contact 11 7.3
How can genital HPV infection be  
prevented?
  sexual abstinence 63 41.7
  condom use 50 33.1
  Vaccination 48 31.8
Knowledge of HPV vaccinec
What is the HPV vaccine used for?
  Prevention of HPV infection 30 66.7
  Prevention of cervical cancer 12 26.7
  Prevention of genital warts 5 11.1
Age group eligible for the 
HPV vaccine
  9–26 years 11 24.4
Notes: aOnly respondents who had heard of cervical cancer; bonly respondents who 
had heard of HPV infection; conly respondents who had heard of HPV vaccine.
Abbreviation: n, number.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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low proportion (70.1%) knew about the association between 
HPV infection and cervical cancer. In similar studies in 
Greece, New Zealand and Thailand the proportions of nurses 
who knew about this association were 78.5%, 71%, and 
81.8% respectively.18–20
Several studies have shown that knowledge of HPV infec-
tion is high in countries with existing national HPV education 
programs. These programs have led to an improved awareness 
and knowledge of HPV infection and related diseases among 
health care providers and the general public.
In this Nigerian study, only a quarter of the nurses who 
had heard about the vaccines knew they were for the preven-
tion of cervical cancer. This is relatively low compared with 
39.1% in the Thailand.20 The poor knowledge of the HPV 
vaccines among the nurses in this Nigerian study may be due 
to the lack of HPV and cervical cancer education programs in 
Nigeria. The vaccines were launched in Nigeria in September 
2008, long after the study was conducted.
Over two-thirds of the female nurses were willing to be 
  vaccinated. This is a similar result to that obtained from nurses 
in the Thai study.20 Most (67.4%) of the nurses were also will-
ing to recommend the HPV vaccines for preadolescent girls. 
This finding is consistent with what has been reported in other 
recent studies.9,10,15,17,21 These studies found there was a high 
level of public interest in HPV vaccination, despite an overall 
low knowledge about HPV infection and related diseases. 
Studies have also shown that the main predictors of providers’ 
intention to recommend HPV vaccination are endorsement by 
professional organizations and provider knowledge of and atti-
tude toward HPV vaccination.19,21,22 Likewise, the authors found 
that the nurses who were willing to be vaccinated were more 
likely to recommend the vaccine for preadolescent girls.
The main reason given by many of the nurses for not 
accepting the HPV vaccines or recommending them for 
preadolescent girls was insufficient information about the 
efficacy and safety of the vaccines. Another reason given 
was that preadolescent girls were not at risk for HPV infec-
tion or cervical cancer and therefore had no need for the 
vaccines. Other studies have also identified these factors as 
barriers to effective HPV immunization.10,23–25 Almost all of 
the nurses expressed their desire to receive more information 
about the vaccines.
The potential limitations of this study include the relatively 
small sample size and the fact that, as a self-  administered 
Table 3 relationship between awareness of human papillomavirus (HPV) infection, cervical cancer, and HPV vaccines and acceptance 
of these vaccines
Awareness Willingness to receive HPV vaccine
Yes (n = 125) No (n = 53) χ2-Test P-value
ever heard of HPV infection?
  Yes 104 47 0.87 0.351
  no 21 6
ever heard of cervical cancer?
  Yes 124 53 nA 1.000*
  no 1 0
ever heard of HPV vaccine?
  Yes 32 13 0.02 0.880
  no 93 40
Intention to recommend HPV vaccine to preadolescent girls
Yes (n = 120) No (n = 58) χ2-Test P-value
ever heard of HPV infection?
  Yes 104 47 0.96 0.326
  no 16 11
ever heard of cervical cancer?
  Yes 119 58 nA 1.000*
  no 1 0
ever heard of HPV vaccine?
  Yes 31 14 0.06 0.807
  no 89 44
Willing to receive vaccine?
  Yes 97 28 19.82 ,0.001
  no 23 30
Note: *Fisher’s exact test.
Abbreviations: nA, not available; n, number.International Journal of Women’s Health
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questionnaire was used to collect data, it is possible that some 
respondents might have given incorrect information.
Conclusion
The knowledge of the HPV infection and vaccines among 
female nurses in this study was poor. Despite their poor 
knowledge, most of the nurses were willing to be vaccinated 
and would recommend the vaccines for preadolescent girls. 
The main reason given overall for not recommending the 
vaccines was lack of information. There is an urgent need 
to bridge this information gap through a well-designed HPV 
education program integrated into a national cervical cancer 
prevention and control program.
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